Pacific Biosciences Of California PACB
NASDAQ PACB
$2.23 -0.13 (-5.30%)
As of: Nov 10, 2026 · 1:38 PM EST

Pacific Biosciences Of California (PACB) Construction in Progress (2016)

Updated

Pacific Biosciences Of California's Construction in Progress was $5.8 million in Q4 2016.

Analysis

Pacific Biosciences Of California (PACB) Construction in Progress (2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Thermo Fisher Scientific 265.71 Bn 242.23 Bn 5.13 Bn -
2 Abbott Laboratories 189.37 Bn 163.23 Bn 7.39 Bn -
3 Danaher 164.78 Bn 144.43 Bn 3.84 Bn -
4 Intuitive Surgical 157.85 Bn 138.13 Bn 2.08 Bn -
5 Medtronic 129.66 Bn 94.91 Bn 6.34 Bn -
6 Stryker 121.82 Bn 108.01 Bn 4.25 Bn -
7 Boston Scientific 63.42 Bn 58.86 Bn 3.43 Bn 976.00 Mn
8 Edwards Lifesciences 59.49 Bn 42.69 Bn 1.35 Bn -
9 Becton Dickinson 58.38 Bn 55.53 Bn 2.32 Bn -
10 Pacific Biosciences Of California 703.42 Mn -288.34 Mn 13.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 5.80 Mn
API Access

Pacific Biosciences Of California Construction in Progress API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=construction-in-progress&ticker=PACB&period=max&api_key=YOUR_API_KEY